Cyber Motorica is positioned among the top global players in upper-limb prosthetics. What is your strategic vision for India within this global roadmap?

Our vision is to develop India as a key hub for clinical expertise, digital prosthetics delivery, and localized innovation. This includes working closely with leading clinical and academic institutions to strengthen practical skills, support knowledge exchange, and improve adoption of modern prosthetic solutions.

We are focusing on an ecosystem-driven approach. This means combining high-tech devices with accessible delivery models and expanding reach beyond major cities. One example is the use of digital prosthetics, an innovative approach in prosthetics including 3D scanning, digital modeling, and 3D printing, which help simplify and accelerate the production process.

Over time, our goal is to move from limited access to scalable access — ensuring that advanced prosthetic technologies are not only available, but also practical, affordable, and aligned with the everyday needs of patients across India.

What does your current manufacturing and supply chain footprint look like? Are you producing devices entirely in India, or do you use a global manufacturing model?

Our current model is a hybrid global and local approach, designed to balance precision manufacturing with regional responsiveness. At present, advanced prosthetic components are supported by our global manufacturing infrastructure to ensure consistency in quality and performance. In parallel, we have built a growing clinical and distribution network across India, with more than 40 partner clinics, to enable efficient fitting, delivery and patient support.

Looking ahead, our strategy is focused on gradual localization of manufacturing in India. We are preparing to introduce local production of selected high-demand models, alongside expanding our digital prosthetics program based on 3D scanning and printing technologies. This approach allows us to significantly reduce production and logistics costs, shorten delivery times, and make advanced prosthetic solutions more accessible.

Ultimately, this hybrid-to-local model is aimed at building a scalable and sustainable prosthetics ecosystem in India — one that combines global technological standards with local accessibility and speed.

Prosthetics is both a medical and a consumer decision. How do you balance affordability with cutting-edge innovation? Are you exploring financing models, insurance partnerships, or government collaborations to expand reach?

Affordability in prosthetics requires a structural approach rather than incremental pricing adjustments. Our focus is on redesigning the entire delivery model to make advanced solutions more accessible without compromising quality.

One key lever is digital prosthetics. Technologies such as 3D scanning, photogrammetry, and remotemodelling allow us to significantly reduce production time, minimize manual processes, and lower overall costs. This is already improving both efficiency and consistency in device delivery.

In parallel, we are expanding our product portfolio across multiple price segments. This allows users to choose solutions that match their needs and budget — from more advanced bionic systems to reliable, cost-efficient myoelectric devices.

Finally, localization plays a critical role. As we move toward local manufacturing and assembly in India, we expect further reductions in cost and delivery time, making high-quality prosthetics accessible to a much broader population.

Motorica is known for its bionic prosthetics and innovations like optical sensing. How close are we to truly intuitive, human-like prosthetic control?

We are at a stage where prosthetics are transitioning from mechanical tools to intent-driven systems.

Modern myoelectric devices already translate muscle signals into movement in real time, enabling intuitive control for everyday tasks. With emerging technologies such as optical sensing, systems can detect more subtle signals — including micro-movements and phantom gestures — improving precision and responsiveness.

Another important shift is adaptive learning. These systems are no longer static; they improve with use, adjusting to individual movement patterns and becoming more natural over time.

While full replication of a biological limb is still a long-term goal, the gap between intention and action is narrowing rapidly. The next phase will be driven by deeper integration of AI, advanced sensing, and neurotechnologies, including sensory feedback, which already shows strong results in improving user experience and reducing phantom pain.

Can you explain how your digital prosthetics programme, which uses 3D scanning and modelling, is changing turnaround time and patient experience?

Digital prosthetics is fundamentally changing how care is delivered, especially in markets like India where access and infrastructure remain uneven. By replacing traditional casting methods with 3D scanning, photogrammetry and digital modelling, we are able to significantly reduce the time required for measurement, design and production. This not only improves accuracy but also minimizes the need for repeated clinical visits which is especially important for patients in remote regions.

In practical terms, clinics can now capture patient data using simple digital tools and we can deliver customized prosthetics in a much shorter timeframe. The larger impact is on access and this model enables smaller clinics and centres even in non-metro regions to deliver advanced prosthetic solutions, helping bridge the gap between urban and underserved areas.

Can you share insights into your current revenue scale and growth trajectory? Which markets contribute most to your revenue today?

We are seeing steady growth driven by a combination of product innovation and geographic expansion. Today, our solutions are used by patients in 15 countries, with strong contributions from both Europe and Asia. India is emerging as one of the fastest-growing markets within this portfolio, supported by increasing awareness, improving clinical capabilities, and demand for more accessible solutions.

In India, our focus is on building long-term capability rather than short-term scale. This includes expanding our clinical network — now covering more than 40 partner clinics — as well as advancing digital prosthetics and preparing for localized manufacturing. These investments are already translating into increased adoption and will play a key role in our next phase of growth.

How do you see the convergence of robotics, AI, and neuroscience reshaping prosthetic care over the next decade?

The convergence of robotics, AI, and neuroscience will fundamentally redefine prosthetic care. Artificial intelligence will enable devices to learn and adapt in real time, making control more intuitive and personalized. Robotics will continue to improve precision, durability, and functional capability. At the same time, advances in neuroscience will strengthen the connection between prosthetics and the human nervous system.

We are already seeing early results of this convergence. For example, Motorica conducts the research on sensory feedback technologies that allow patients to sense the touch through prosthesis and reduce the phantom pain in the absent limb. Today the research’s participants are able to perceive object characteristics such as size and texture, while also significantly reducing phantom pain.

Over the next decade, the focus will shift from compensation to integration — where prosthetic systems are not just assistive tools, but a seamless extension of the human body, enabling greater independence, confidence, and quality of life.